• Sonuç bulunamadı

Lipid-Rich Cell Wall of Mycobacterium

N/A
N/A
Protected

Academic year: 2021

Share "Lipid-Rich Cell Wall of Mycobacterium"

Copied!
34
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Mycobacterium

(2)

Mycobacterium tuberculosis Mycobacterium leprae (uncommon)

Mycobacterium avium-intracellulaire Complex (MAC) or (M. avium)

Important Human Pathogens

(3)

Lipid-Rich Cell Wall of Mycobacterium

Mycolic acids

CMN Group:

Unusual cell wall lipids (mycolic acids,etc.)

(Purified Protein Derivative)

(4)

Acid-Fast (Kinyoun) Stain of Mycobacterium

NOTE: cord growth (serpentine

arrangement) of virulent strains

(5)

Photochromogenic Mycobacterium kansasii on Middlebrook Agar

NOTE: Mycobacteria pathogenic for humans can be differentiated (Runyon Groups) by:

 speed of growth (all are slower than most other pathogens) and by

 production of chromogenic

pigments (in light, in dark,

or none)

(6)

Improved Mycobacterial Isolation Medium

(7)

Eight Week Growth of

Mycobacterium tuberculosis on

Lowenstein-Jensen Agar

(8)

Pathogenic Mycobacterium spp.

BCG

AIDS patients

(9)

Mycobacterial Clinical Syndromes

(10)

Diagram of a

Granuloma

NOTE:

ultimately a fibrin layer develops around granuloma (fibrosis), further

“walling off” the lesion.

Typical progression in pulmonary TB

involves caseation, calcification and cavity formation.

(11)

Laboratory Diagnosis of Mycobacterial Disease

Nucleic acid probes

Nucleic acid sequencing

(12)

Differential Characteristics of Commonly Isolated

Mycobacterium spp.

(13)

Mycobacterium

tuberculosis

(14)

Mycobacterium tuberculosis

Infections

(15)

Incidence of Tuberculosis in USA

(16)

Mycobacterium tuberculosis Infections

(cont.)

BCG (bacille Calmette-Guerin)

= attenuated M. bovis

Positive PPD + Chest X-Ray +

MDR-TB a serious global health threat

(17)

 Pneumonia

 Granuloma formation with fibrosis

 Caseous necrosis

• Tissue becomes dry & amorphous (resembling cheese)

• Mixture of protein & fat (assimilated very slowly)

 Calcification

• Ca++ salts deposited

 Cavity formation

• Center liquefies & empties into bronchi

Typical Progression of

Pulmonary Tuberculosis

(18)

PPD Tuberculosis Skin Test Criteria

PPD = Purified Protein Derivative from M. tuberculosis

(19)

Chest X-Ray of Patient with Active

Pulmonary Tuberculosis

(20)

Mycobacterium Tuberculosis

Stained with Fluorescent Dye

(21)

Mycobacterium leprae

(22)

Mycobacterium leprae Infections

(23)

Mycobacterium leprae Infections

(cont.)

(24)

Tuberculoid vs. Lepromatous Leprosy

Clinical Manifestations and Immunogenicity

(25)

Lepromatous vs. Tuberculoid Leprosy

(26)

Lepromatous Leprosy (Early/Late Stages)

(27)

Lepromatous Leprosy Pre-

and Post-Treatment

(28)

Clinical Progression of Leprosy

(29)

Effect of Cell-Mediated Immunity on

Leprosy Clinical Outcome

(30)

Mycobacterium avium- intracellulaire Complex

(MAC)

(31)

Mycobacterium avium-intracellulaire Infections

(32)

Mycobacterium avium-intracellulaire Infections

(33)

M. avium-

intracellulaire Complex (MAC) Progression vs.

CD4 Count in

AIDS Patients

(34)

Mycobacterium avium-intracellulaire in Tissue Specimens

Low Magnification High Magnification

Referanslar

Benzer Belgeler

QFT pozitiflik oranlarının genel olarak yaşla doğru orantılı olarak arttığı, be- lirsiz sonuçlar değerlendirme dışı bırakıldığında en düşük pozitiflik oranlarının

Düzce İlinde İzole Edilen Mycobacterium tuberculosis Kompleks Suşlarında Mycobacterium bovis subsp.. bovis

Bu çalışmada, Manisa bölgesinde farklı hastalardan izole edilen ve PZA dışındaki tüm primer antitüberküloz ilaçlara duyarlı 109 MTBC klinik izolatının PZA duyarlılık

[r]

The leading organizations engaged in research on “toxicity of knee implants” had been found out by the volume of publications and citation analysis, the parameters used are the

Özmen E, Aslan A, Uçar M, Erzurum bölge tüberküloz laboratuvarında izole edilen Mycobacterium tuberculosis kompleksi suşlarının primer anti- tüberküloz ilaçlara

Primer antitüberküloz ilaçlar- dan en azından İNH ve RİF direnci gösteren izolatlar “çok ilaca dirençli (ÇİD)” olarak tanım- lanmakta ve 2010 yılı için

uygulaması ve neTcesi ile ilgili hususlarda Sığır Tüberkülozu Yönetmeliği uygulanır. f) Tüberküloz hastalığı çıkan ahırlara dezenfekte edilmedikçe hayvan